# Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease

> **NCT00595244** · PHASE3 · COMPLETED · sponsor: **Point Biomedical** · enrollment: 456 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** PB127 for injectable suspension

## Key facts

- **NCT ID:** NCT00595244
- **Lead sponsor:** Point Biomedical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2003-10
- **Final completion:** 2003-10
- **Target enrollment:** 456 (ACTUAL)
- **Last updated:** 2008-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00595244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00595244, "Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00595244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*